Deborah J. Castelbuono

Statistics

Publications

Citations

260

H-Index

Active since

2000

Affiliations

Pfizer (United States)(Current)

Newcastle University

Deborah J. Castelbuono is an author at Pfizer (United States) specializing in medicine, poly(adp-ribose) polymerase inhibitors, and pediatric chemotherapy.

Publications per year

2000–2010

Publications

Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma

Rachel Daniel, Agata Rozanska, Huw D. Thomas et al. · Clinical Cancer Research · 2009 · 82 citations

Medicine, Oncology, Pharmacology +15

<i>Ex Vivo</i> Gene Therapy Using Targeted Engraftment of NGF-Expressing Human NT2N Neurons Attenuates Cognitive Deficits Following Traumatic Brain Injury in Mice

Luca Longhi, Deborah Watson, Kathryn E. Saatman et al. · Journal of Neurotrauma · 2004 · 80 citations

Medicine, Neurobiology, Neuroscience +17

Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699

Rachel Daniel, Agata Rozanska, Evan A. Mulligan et al. · British Journal of Cancer · 2010 · 55 citations · Full text

Medicine, Oncology, Pharmacology +15

Molecular Structure and Activity Toward DNA of Baicalein, a Flavone Constituent of the Asian Herbal Medicine “Sho-saiko-to”

Miriam Rossi, R. J. Meyer, Pamela E. Constantinou et al. · Journal of Natural Products · 2000 · 43 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

1–4 of 4